Literature DB >> 21631427

The burden of metabolic diseases amongst HIV positive patients on HAART attending The Johannesburg Hospital.

Henry Julius1, Debashis Basu, Elena Ricci, Jeffrey Wing, Jayati Kusari Basu, Daria Pocaterra, Paolo Bonfanti.   

Abstract

South Africa has the highest prevalence of human immunodeficiency virus (HIV) infection in the world. The improved life expectancy, due to the recent introduction of highly active antiretroviral therapy (HAART), may lead to an increased health burden related to metabolic disorders, resulting in an increased pressure on health-care services. The main objective of this study was to determine the prevalence of hypertension, diabetes, obesity and dyslipidemia in a sample of HAART-treated HIV infected patients, attending an HIV clinic in the Gauteng province. This was a cross-sectional study of 304 HIV positive patients enrolled between January 2009 and March 2009, including patients aged 18 to 45 years, on HAART for more than one year. Hypertension prevalence was 19.1% (95% confidence interval (CI) 14.7-23.5): 23.9% in men and 17.7% in women (P=0.10). Diabetes was diagnosed in 4 women. Hypercholesterolemia (total cholesterol >5.00 mmol/mL) was found in 32.2% (95% CI 27.0-37.5), low HDL cholesterol (<1.20 mmol/mL) in 45.7% (95% CI 40.1-51.3) and elevated LDL cholesterol (>4.10 mmol/mL) in 9.5% (95% CI 6.2-12.8); these prevalences were not different between sexes, whereas hypertriglyceridemia (>2.25 mmol(mL) (15.8%, 95% CI 11.7-19.9) was significantly more frequent in men (28.4% versus 12.2%, P=0.002). TC and LDL-C were positively correlated with CD4+ cell count (r=0.13, P=0.03 and r=0.12, P=0.03). In this sample, the traditional risk factors for cardiovascular disease had a high prevalence, despite the young age of our patients. Women seemed to be at higher risk than man, unlike other HIV populations where these comparisons were made (Uganda, Italy and Norway). Obesity and lipid abnormalities, highly prevalent in the general population, also appeared related to HIV-infection and CD4+ cell count, presumably as a consequence of ART exposure. Further studies are needed in order to survey a population where HIV infection is turning into a chronic disease, with its complications.

Entities:  

Mesh:

Year:  2011        PMID: 21631427     DOI: 10.2174/157016211796320360

Source DB:  PubMed          Journal:  Curr HIV Res        ISSN: 1570-162X            Impact factor:   1.581


  31 in total

1.  Noncommunicable diseases among HIV-infected persons in low-income and middle-income countries: a systematic review and meta-analysis.

Authors:  Pragna Patel; Charles E Rose; Pamela Y Collins; Bernardo Nuche-Berenguer; Vikrant V Sahasrabuddhe; Emmanuel Peprah; Susan Vorkoper; Sonak D Pastakia; Dianne Rausch; Naomi S Levitt
Journal:  AIDS       Date:  2018-07-01       Impact factor: 4.177

2.  Models of integration of HIV and noncommunicable disease care in sub-Saharan Africa: lessons learned and evidence gaps.

Authors:  Benson Njuguna; Susan Vorkoper; Pragna Patel; Mike J A Reid; Rajesh Vedanthan; Colin Pfaff; Paul H Park; Lydia Fischer; Jeremiah Laktabai; Sonak D Pastakia
Journal:  AIDS       Date:  2018-07-01       Impact factor: 4.177

Review 3.  Role of Noncommunicable Diseases (NCDs) in Resource-Limited Settings (RLS).

Authors:  Mosepele Mosepele; Elizabeth Botsile
Journal:  Curr HIV/AIDS Rep       Date:  2018-04       Impact factor: 5.071

Review 4.  The burden of diabetes and hyperlipidemia in treated HIV infection and approaches for cardiometabolic care.

Authors:  Katherine Samaras
Journal:  Curr HIV/AIDS Rep       Date:  2012-09       Impact factor: 5.071

5.  The Effect of Diabetes and Prediabetes on Mycobacterium tuberculosis Transmission to Close Contacts.

Authors:  María B Arriaga; Michael S Rocha; Betânia M F Nogueira; Vanessa Nascimento; Mariana Araújo-Pereira; Alexandra B Souza; Alice M S Andrade; Alysson G Costa; Adriano Gomes-Silva; Elisangela C Silva; Marina C Figueiredo; Megan M Turner; Betina Durovni; José R Lapa-E-Silva; Afrânio L Kritski; Solange Cavalcante; Valeria C Rolla; Marcelo Cordeiro-Santos; Timothy R Sterling; Bruno B Andrade
Journal:  J Infect Dis       Date:  2021-12-15       Impact factor: 5.226

Review 6.  Epidemiology of coronary heart disease in patients with human immunodeficiency virus.

Authors:  Virginia A Triant
Journal:  Rev Cardiovasc Med       Date:  2014       Impact factor: 2.930

7.  Diabetes and Hypertension among Patients Receiving Antiretroviral Treatment Since 1998 in Senegal: Prevalence and Associated Factors.

Authors:  Assane Diouf; Amandine Cournil; Khadidiatou Ba-Fall; Ndèye Fatou Ngom-Guèye; Sabrina Eymard-Duvernay; Ibrahima Ndiaye; Gilbert Batista; Papa Mandoumbé Guèye; Pape Samba Bâ; Bernard Taverne; Eric Delaporte; Papa Salif Sow
Journal:  ISRN AIDS       Date:  2012-12-01

8.  Hypertension in sub-Saharan Africa: cross-sectional surveys in four rural and urban communities.

Authors:  Marleen E Hendriks; Ferdinand W N M Wit; Marijke T L Roos; Lizzy M Brewster; Tanimola M Akande; Ingrid H de Beer; Sayoki G Mfinanga; Amos M Kahwa; Peter Gatongi; Gert Van Rooy; Wendy Janssens; Judith Lammers; Berber Kramer; Igna Bonfrer; Esegiel Gaeb; Jacques van der Gaag; Tobias F Rinke de Wit; Joep M A Lange; Constance Schultsz
Journal:  PLoS One       Date:  2012-03-12       Impact factor: 3.240

9.  Missed Opportunities to Address Cardiovascular Disease Risk Factors amongst Adults Attending an Urban HIV Clinic in South Africa.

Authors:  Miriam Rabkin; Anthony Mutiti; Christine Chung; Yuan Zhang; Ying Wei; Wafaa M El-Sadr
Journal:  PLoS One       Date:  2015-10-08       Impact factor: 3.240

10.  Risk Factors of Cardiovascular Diseases in HIV/AIDS Patients on HAART.

Authors:  Dickson Shey Nsagha; Jules Clement Nguedia Assob; Anna Longdoh Njunda; Elvis Asangbeng Tanue; Odette Dzemo Kibu; Charlotte Wenze Ayima; Marcelin Ngowe Ngowe
Journal:  Open AIDS J       Date:  2015-10-20
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.